Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Some patients achieved a loss of an average of 15% of their body weight over 68 weeks, a result significantly higher than that achieved with other diabetes medications
ColonBroom offers a 30-day money-back guarantee, giving you the confidence to try the product risk-free
If you are choosing between EllieMD injectable and oral options, the injectable route offers more predictable absorption and outcomes based on current evidence
Identifier: NCT05931367
Summary: Microdosing GLP-1 for Hashimoto's is an unapproved, off-label practice lacking clinical evidence, and the NHS does not recommend GLP-1 receptor agonists for thyroid conditions without concurrent type 2 diabetes or obesity meeting specific criteria
